# Cytovale Inc.

Canonical: https://abierto.us/vendors/cytovale-inc-tg7hm4hd8594

- UEI: TG7HM4HD8594
- CAGE: 6PS42
- Location: San Francisco, CA
- Awards in window: 1 (6 transactions), $0 obligated, May 31, 2024 to May 7, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $0

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50123C00066 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. Cytovale: the Overall Objective of This Contract Is to Evaluate the Impact of the Intellisep Test on Clinical Decision-Making and Its Potential to Aid in Improving Sepsis Risk Stratification and Resource Utilization. the Contract Will Support the Squ. https://www.usaspending.gov/award/CONT_AWD_75A50123C00066_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/cytovale-inc-tg7hm4hd8594.